Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CERT US Equity

Certara, Inc.Information Technology · Services-Prepackaged Software · CIK 1827090 · FY ends Dec 31
$8.01
+0.01 (+0.12%)
USD · as of 2026-08-18 · marketstack
1 registered study · 0 active

Studies where CERT is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

1 observational

Held by 11 tracked-famous managers (MILLENNIUM MANAGEMENT LLC, AQR CAPITAL MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, +6 more) · FINRA short interest 7.7 days to cover (settled 2026-07-31) · government filings 180d: 0 congress / 2 executive

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global)NCT04626076observationalOccurrence of SARS-CoV-2 infection among HCWs caring for COVID-19 patients, in terms of time, geography, healthcare setting, type of HCW.Study Protocol · Statistical Analysis PlanCompletedOther: Comparative Observational Cohort StudySARS-CoV Infection, Covid196,8082021-08-05actual2023-04-04

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19